Background Image
Table of Contents Table of Contents
Previous Page  36 / 52 Next Page
Information
Show Menu
Previous Page 36 / 52 Next Page
Page Background

74

VOLUME 15 NUMBER 2 • NOVEMBER 2018

PASCAR ROADMAP

SA JOURNAL OF DIABETES & VASCULAR DISEASE

Roadmap to achieve 25% hypertension control in

Africa by 2025

Anastase Dzudie, Brian Rayner, Dike Ojji, Aletta E Schutte, Marc

Twagirumukiza, Albertino Damasceno, Seringe Abdou Ba, Abdoul Kane, Euloge

Kramoh, Jean Baptiste Anzouan Kacou, Basden Onwubere, Ruth Cornick, Karen

Sliwa, Benedict Anisiuba, Ana Olga Mocumbi, Elijah Ogola, Mohamed Awad,

George Nel, Harun Otieno, Ali Ibrahim Toure, Samuel Kingue, Andre Pascal

Kengne, Pablo Perel, Alma Adler, Neil Poulter, Bongani Mayosi, on behalf of

the PASCAR task force on hypertension

Correspondence to: Anastase Dzudie

Department of Internal Medicine, Yaoundé Faculty of Medicine and

Biomedical Sciences, Yaoundé, Cameroon

e-mail:

aitdzudie@yahoo.com

Samuel Kingue

Department of Internal Medicine, Yaoundé Faculty of Medicine and

Biomedical Sciences, Yaoundé, Cameroon

Anastase Dzudie, Karen Sliwa, Bongani Mayosi

Department of Medicine, University of Cape Town, Cape Town, South Africa

Anastase Dzudie, Karen Sliwa

Hatter Institute for Cardiovascular Research in Africa, Department of

Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town,

South Africa

Brian Rayner

Division of Nephrology and Hypertension, Department of Medicine, Groote

Schuur Hospital and University of Cape Town, Cape Town, South Africa

Dike Ojji

Department of Medicine, Faculty of Health Sciences, University of Abuja;

Cardiology Unit, Department of Medicine, University of Abuja Teaching

Hospital, Gwagwalada, Abuja, Nigeria

Aletta E Schutte

Hypertension in Africa Research Team (HART); MRC Unit for Hypertension

and Cardiovascular Disease, North-West University, Potchefstroom, South

Africa

Marc Twagirumukiza

College of Medicine and Health Sciences, University of Rwanda, Kigali,

Rwanda and African Society of Hypertension (AfSoH) Initiative, Heymans

Institute of Pharmacology, Ghent University, Ghent, Belgium

Albertino Damasceno

Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique

Seringe Abdou Ba

Le Dantec University Teaching Hospital, Dakar, Senegal

Abdoul Kane

Service de cardiologie, Hôpital Général de Grand Yolf, Dakar, Senegal

Euloge Kramoh, Jean Baptiste Anzouan Kacou

Institut cardiologique d’Abidjan, Abidjan, Cote d’Ivoire

Basden Onwubere

Department of Medicine, University of Nigeria Teaching Hospital, Enugu,

Nigeria

Ruth Cornick

Knowledge Translation Unit, University of Cape Town Lung Institute and

Department of Medicine, University of Cape Town, Cape Town, South Africa

Benedict Anisiuba

Department of Medicine, University of Nigeria Teaching Hospital, Enugu,

Nigeria

Ana Olga Mocumbi

National Health Institute, Mozambique and University Eduardo Mondlane,

Maputo, Mozambique

Elijah Ogola

Department of Clinical Medicine and Therapeutics, University of Nairobi,

Kenya

Mohamed Awad

Division of Cardiology, University of Khartoum, Khartoum, Sudan

George Nel

Pan-African Society of Cardiology (PASCAR), Cape Town, South Africa

Harun Otieno

Section of Cardiology, Department of Medicine, Aga Khan University

Hospital, Nairobi, Kenya

Ali Ibrahim Toure

Division of Cardiology, University of Khartoum, Sudan

Andre Pascal Kengne

Medical Research Council, Cape Town, South Africa

Pablo Perel, Alma Adler

Science Advisory Unit, World Heart Federation, Geneva, Switzerland and

London School of Hygiene and Tropical Medicine, London, UK

Neil Poulter

International Centre for Circulatory Health, Imperial College, London, UK

Previously published in

Cardiovasc J Afr

2017;

28

(4): 261–272

Co-published in

Global Heart

2017

S Afr J Diabetes Vasc Dis

2018;

15

: 74–85